Ghana is set to introduce an HIV preventive vaccine by 2026 in a major step toward reducing new infections and strengthening its fight against the virus.
Announcing the initiative at a press briefing in Accra, the Director-General of the Ghana AIDS Commission, Dr. Prosper Akanbong, described the rollout as a “milestone in HIV prevention.” He explained that while the first batch of vaccines will be sourced from abroad, plans are underway for local pharmaceutical companies to begin production with technical support from the German development agency, GIZ.
“Together with GIZ, we are on track. By late 2026 or early 2027, Ghana should be able to produce its own vaccines,” Dr. Akanbong said.
The move comes as Ghana continues to grapple with high infection rates, with more than 15,000 new HIV cases recorded in 2023. Current data from UNAIDS estimate that about 354,000 people are living with HIV in the country, with women and young people being most affected.
The Ashanti, Greater Accra, and Eastern regions carry the highest burden of cases. Public health experts warn that stigma, limited testing, and late detection remain barriers to treatment, even as access to antiretroviral therapy has expanded.
Health officials believe the preventive vaccine could be a “game-changer” in cutting transmission, particularly among high-risk groups. Pilot programmes and rollout priorities are expected to be announced in the coming months.
Beyond prevention, the initiative is also expected to boost Ghana’s pharmaceutical industry by building local vaccine production capacity.
